Delivery Order SPE2DB24D2106-SPE2DB26FAUAC
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,745.97 by the Defense Logistics Agency (DLA) on September 19, 2025. The delivery order, which carries no set-aside designation, covers the supply of Yuvafem 10 microgram vaginal inserts (18 units) with performance at the company's facility in Conshohocken, Pennsylvania, and an ultimate completion date of September 22,...
- The Defense Logistics Agency awarded a delivery order valued at $3,125.54 to DMS Pharmaceutical Group Inc. for Yuvafem 10 microgram vaginal inserts (18-unit package), with performance in Conshohocken, Pennsylvania and completion by September 5, 2025. This firm fixed-price delivery order was awarded without a set-aside designation on September 4, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as the prime...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,238.56 by the Defense Logistics Agency (DLA) on August 14, 2025. The delivery order, which has a firm fixed-price structure with an ultimate completion date of August 15, 2025, covers the supply of Yuvafem 10 micrograms vaginal inserts (18 count). This award was issued without a set-aside designation, and performance will be completed at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of Yuvafem 10 MCG vaginal inserts, with a total ceiling value of $1,611.60 and an ultimate completion date of July 9, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in providing a range of pharmaceutical products to federal agencies,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,916.25 firm fixed-price award is for the delivery of YUVAFEM 10 MCG vaginal inserts. The award is under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC vehicle, under the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,659.73 contract is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized pharmaceutical product. The contract has an ultimate completion date of July 17, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,813.40 delivery order is for the provision of YUVAFEM 10 MCG vaginal inserts. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue firm...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,906.93, is for the delivery of 4564788297 ! YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized pharmaceutical product, with a completion date of June 4, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and...
- This federal contract award, valued at $9,104.55, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award is a delivery order under the DLA's SPE2DB program, a single-award indefinite delivery contract (IDC) valued up to $499,999,999 that runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,621.42 for 1,000 units of Estrogens 0.625mg by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract is a firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of August 26, 2025. This delivery order falls under DMS Pharmaceutical Group's larger single-award...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB26FAUACDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,478.02 to DMS Pharmaceutical Group Inc. for Yuvafem 10 mcg vaginal inserts (18-count units) on October 29, 2025, with performance completion scheduled for October 30, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The award is structured as a firm fixed-price delivery order issued under the company's broader Indefinite Delivery Contract with DLA. This delivery order is issued under DMS Pharmaceutical Group's participation in the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award IDC designated SPE2DR, valued at $499,999,999 with a completion date of December 31, 2036, which authorizes DLA to issue delivery orders for branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables. The company's established performance across numerous prior delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements for the federal military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 10/29/25 |